Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$2.38 – $9.55
6% from low
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.84B | $9.21B | $8.48B | $9.79B | $9.96B | $10.33B | $10.70B | $2.76B |
| Cost of revenue | $8.47B | $8.08B | $7.20B | $8.27B | $8.13B | $8.21B | $8.48B | $0 |
| Gross profit | $1.37B | $1.13B | $1.28B | $1.51B | $1.83B | $2.13B | $2.22B | $0 |
| Gross margin | 13.9% | 12.3% | 15.1% | 15.5% | 18.3% | 20.6% | 20.7% | 0.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$392.2M | $73.2M | $204.1M | $368.5M | $142.9M | $104.5M | −$207.8M | $27.5M |
| EBITDA | −$272.7M | $186.7M | $323.4M | $415.5M | $368.4M | $390.6M | $515.2M | $101.1M |
| Net income | −$437.0M | −$62.4M | $29.9M | $221.6M | $22.4M | −$41.3M | −$362.7M | −$1.10B |
| Net margin | -4.4% | -0.7% | 0.4% | 2.3% | 0.2% | -0.4% | -3.4% | -39.8% |
| EPS (diluted) | -7.28 | -0.37 | 0.47 | 2.94 | 0.29 | -0.55 | -4.73 | -14.24 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2.6B | $0.97 | $0.90–$1.10 | 3 |
| 2027 | $2.8B | $1.16 | $1.13–$1.18 | 1 |
| 2028 | $3.0B | $1.27 | $1.24–$1.30 | 1 |
| 2029 | $2.5B | $1.42 | $1.39–$1.45 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds OMI.
No tracked institution reports a position in OMI as of their last filing.
| Execution date | Ratio |
|---|---|
| 2010-04-01 | 3-for-2 |
No one on the platform has traded OMI yet.
| $496M |
| — |
| CGCCanopy Growth Corporation | $0.95 | +3.59% | $399M | — |
| CVRXCVRx, Inc. | $5.86 | +11.62% | $156M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.0× sales vs its 0.2× historical median P/S.
Fair value ≈ $16.81 · price $2.80 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.